Tribenoside

Research use only, not for human use.

Tribenoside is a vasoprotectant with mild anti-inflammatory, analgesic, and wound healing properties.

Tribenoside is a vasoprotectant with mild anti-inflammatory, analgesic, and wound healing properties.(In Vitro):Administration of 1 nM-100 μM Tribenoside exhibits cytotoxic effect(EC50 = 13.74 μM) in HeLa cells.(In Vivo):Oral administration in doses of 500 and 1,200 mg/kg Tribenoside weekly significantly decreases in the development of osteoporosis in male mice.

Tribenoside (1 nM-100 μM) exhibits cytotoxic effect against HeLa cells with the EC50 of 13.74 μM. Cell Viability Assay Cell Line:HeLa cells Concentration:1 nM, 10 nM, 100 nM, 1 μM, 10 μM, 100 μM Incubation Time:72 hours Result:Reduced HeLa cells viability in a dose-responsive manner.

Tribenoside (oral administration in doses of 500 and 1,200 mg/kg weekly) significantly decreases in the development of osteoporosis. Animal Model:male C57 black mice Dosage:500 and 1,200 mg/kg weekly Administration:Oral administration Result:Led to a significant reduction in the overall arthrotic involvement.

Ba 2140 | BG-356 | Glivenol | Glyvenal | Glyvenol | TBGF

Others

Other Targets

EP3

——

——

10310-32-4

478.585

C29H34O6

>98% (HPLC)

——

CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O

——

(-20℃)

With Ice Pack

≥ 2 years